Grant Accounting Rules Before Comparing Audit Tools

Federal or foundation grant funding is typically recognized as allowable, allocable costs are incurred against the approved budget, not simply when cash is received or an invoice is sent. That means the reconciliation isn't just billed-versus-collected, it's actual costs incurred against the specific budget line items the grant allows, with unallowable costs, certain types of entertainment or unrelated overhead, tracked and excluded.

A firm treating grant funding like a standard client invoice risks drawing down funds against costs the grant doesn't actually permit, which surfaces as a finding in the funder's own compliance review, separate entirely from a financial statement audit.

Grant budgets typically apply a negotiated indirect cost, or facilities and administrative, rate to direct costs, and that rate has to be applied consistently and reconciled against actual overhead incurred. If the rate goes stale or gets applied inconsistently across grants, every grant's cost reporting drifts, not just one.

Reconciling costs incurred against budget, by grant, by budget line item, every month is close-process work, and it's the kind of high-volume, repeatable check close management software handles well: standardizing the template and flagging any grant where the burn rate against budget looks off pace for the period remaining.

Fee-for-service consulting tied to research milestones, such as a completed study phase or a regulatory filing submitted, can require a documented judgment about when the performance obligation is satisfied under ASC 606, not just whether a milestone was reached or an invoice was sent, so confirm the treatment with your accountant.

Recognizing milestone revenue before the criteria are clearly satisfied, because cash flow pressure makes an early invoice tempting, is a common mistake that creates a real restatement risk if a client or auditor later disputes whether the milestone was genuinely achieved. Document the specific criteria for each milestone in the contract itself, and require sign-off from whoever ran the technical work, not just finance, before revenue is recognized.

Picture a multi-year federal grant where the team draws down funds on a roughly even quarterly schedule out of habit, while the actual research work, subject enrollment, lab analysis, ran behind schedule in an early quarter. By the time anyone reconciles cash drawn against costs actually incurred, the grant shows funds drawn well ahead of allowable costs, which is exactly the kind of variance a funder's compliance review flags.

A monthly reconciliation that ties drawdowns to actual allowable costs incurred, not to a flat quarterly schedule, catches this the same period it happens, letting the team adjust the drawdown pace before it becomes a funder finding rather than after.

Firms managing multiple federal grants alongside private client work increasingly need to demonstrate a documented internal control system covering cost allocation, time and effort reporting, and subrecipient monitoring, requirements that go beyond what a single controller can track from memory across several concurrent awards.

A GRC platform is worth prioritizing once the firm holds several concurrent grants, is preparing for a funder's compliance audit, or is being acquired by a larger CRO or consultancy whose diligence team wants to see these controls documented and tested, not just described.

A short checklist for firms running grants alongside client work:

• Reconcile costs incurred against the specific budget line items each grant allows, and track unallowable costs so they stay excluded.
• Compare cash drawn against allowable costs actually incurred every month, so a drawdown that runs ahead of the work is caught early.
• Apply the negotiated indirect cost rate consistently across every grant, and revisit it if actual overhead shifts.
• Keep time and effort reporting and subrecipient monitoring documented, since one controller cannot track them from memory across several awards.
• Get sign-off from the research lead and finance before recognizing milestone revenue.

Life sciences and biotech engagements routinely involve proprietary research data, formulations, or clinical findings that carry real commercial value to the client, and a consultant working with a client's competitor, even on an unrelated project, raises a confidentiality risk that sits alongside, not inside, the financial accounting. Restricting access to project-specific data rooms and screening for conflicts before staffing a new engagement is a control decision, not a bookkeeping one.

Documenting how that access gets restricted and how conflicts get screened is worth building into the same governance framework that tracks grant compliance, since both are really the same discipline: mapped controls, tested on a schedule, evidenced rather than assumed. Review the access list for each active data room quarterly, since staff turnover and shifting engagement teams are the most common way an old access grant outlives the project it was meant for.